Submandibular glands in the metabolic syndrome

Biomedical Reviews

Volumn 18, Issue , 2007, Pages 65-67

  Hristova, Mariana G ^a   Chaushev, Borislav ^b   Klissarova, Aneliya ^b   Kovacheva, Tanya ^a  

^a Private Endocrinology Consulting Office

^b UNIVERSITY HOSPITAL ST MARINA   (Bulgaria)

Author keywords

BDNF; Cardiometabolic diseases; Echography; NGF; Scintigraphy

Indexed keywords

EID: 78249237582     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: 10.14748/bmr.v18.69     Document Type: Article

References (26)

1. Sharma V, McNeill JH. The etiology of hypertension in the metabolic syndrome part four: the systemic perspective - the role of the neuroendocrine and immune systems, and the challenge of integration. Curr Vasc Pharmacol 2006; 4: 349-381.Item 293-304; 305-320; 321-348.
2. Tarcin O, Bajaj M, Akalin S. Insulin resistance, adipocyte biology, and thiazolidinediones: a review. Metab Syndr Relat Disord 2007; 5: 103-115.
3. Fantuzzi G, Mazzone T, editors. Nutrition and Health: Adipose Tissue and Adipokines in Health and Disease. Humana Press Inc., Tokowa, NJ. 2007.
4. Aloe L, Tirassa P, Bracci-Laudiero L. Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Des 2001; 7: 113-123.
5. Lebrun B, Bariohay B, Moyse E, Jean A. Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview. Auton Neurosci 2006; 126-127: 30-38.
6. Chaldakov GN, Fiore M, Hristova MG, Aloe L. Metabotrophic potential of neurotrophins: implication in obesity and related diseases? Med Sci Monit 2003; 9: HY19-21.
7. Nicholson JR, Peter JC, Lecourt AC, Barde YA, Hofbauer KG. Melanocorin-4 receptor activation stimulates hypothalamic brain-derived neurotrophic factor release to regulate food intake, body temperature and cardiovascular function. J Neuroendocrinol 2007; 19: 974-982.
8. Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova MG, Antonelli A, et al. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardivascualr disease? Prog Brain Res 2004; 146: 279-289.
9. Shyu KG, Liou JY, Wang BW, Fang WJ, Chang H. Carveditol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-loaded rat heart. J Biomed Sci 2005; 12: 409-502.
10. Ieda M, Kanazawa H, Ieda Y, Kimura K, Matsumura K, Tomita Y, et al. Nerve growth factor is critical for cardiac sensory innervation and rescues neuropathy in diabetic hearts. Circulation 2006; 114: 2351-2363.
11. Geroldi D, Minoretti P, Emanuele E. Brain-derived neurotrophic factor and the metabolic syndrome: more than just hypothesis. Med Hypotheses 2006; 67: 195-196.
12. Bulló M, Peeraully MR, Trayhurn P, Folch J, Salas- Salvadó J. Circulating nerve growth factor levels in relation to obesity and the metabolic syndrome in women. Eur J Endocrinol 2007; 157: 303-310.
13. Sposato V, Manni L, Chaldakov GN, Aloe L. Strepto- zotocin-induced diabetes is associated with cahnges in NGF levels in pancreas and barin. Arch Ital Biol 2007; 145: 87-97.
14. Manni L, Nikolova V, Vyagova D, Chaldakov GN, Aloe L. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol 2005; 102: 169-171.
15. Aloe L, Alleva E, Böhm A, Levi-Montalcini R. Aggressive behaviour induces release of nerve growth factor from mouse salivary gland into blood stream. Proc Natl Acad Sci USA 1986; 83: 6184-6187.
16. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154-1162.
17. Aloe L, Fiore M. Submandibular glands, nerve growth factor and neuroinflammatory responses in rodents. Biomed Rev 1998; 9: 93-99.
18. Suzuki H, Amizuka N, Noda M, Amano O, Maeda T. Histological and immunohistochemical changes in the submandibular gland in klotho-deficient mice. Arch Histol Cytol 2006; 69: 119-128.
19. Tsukinoki K, Saruta J, Sasaguri K, Miyoshi Y, Jinbu Y, Kusama M, et al. Immobilization stress induces BDNF in rat submandibular glands. J Dent Res 2006; 85: 844-848.
20. Tsukinoki K, Saruta J, Muto N, Sasaguri K, Sato S, Tan- Ishii N, et al. Submandibular glands contribute to increases in plasma BDNF levels. J Dent Res 2007; 86: 260-264.
21. Besedovsky H, Rey A. Immune-neuroendocrine interactions: facts and hypotheses. Endocr Rev 1996, 17: 64-79.
22. Bellava S, Gallara R. Role of sympathetic neurons system in the control of salivary secretion by environmental stimuli. Biomed Rev 1998; 9: 61-68.
23. Mathison R, Davidson I. Neuroendoncrine regulation of inflammation and tissue repair by submandibular gland factors. Immunol Today 1994; 15: 527-532.
24. Proctor G, Carpenter G. The function of salivary proteins and the regulation of their secretion. Biomed Rev 1998; 9: 3-15
25. Loutfi I, Nair MK, Ebrahim AK. Salivary gland scintigraphy: the use of semiquantitative analysis for uptake and clearance. J Nucl Med Technol 2003; 31: 81-85.
26. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977; 133: 358-366.